These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29287190)

  • 1. A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy.
    Silvestri V; Rizzolo P; Zelli V; Valentini V; Zanna I; Bianchi S; Tibiletti MG; Varesco L; Russo A; Tommasi S; Coppa A; Capalbo C; Calistri D; Viel A; Cortesi L; Manoukian S; Bonanni B; Montagna M; Palli D; Radice P; Peterlongo P; Ottini L
    Breast; 2018 Apr; 38():92-97. PubMed ID: 29287190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
    Kiiski JI; Tervasmäki A; Pelttari LM; Khan S; Mantere T; Pylkäs K; Mannermaa A; Tengström M; Kvist A; Borg Å; Kosma VM; Kallioniemi A; Schleutker J; Bützow R; Blomqvist C; Aittomäki K; Winqvist R; Nevanlinna H
    Breast Cancer Res Treat; 2017 Nov; 166(1):217-226. PubMed ID: 28702895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
    Neidhardt G; Hauke J; Ramser J; Groß E; Gehrig A; Müller CR; Kahlert AK; Hackmann K; Honisch E; Niederacher D; Heilmann-Heimbach S; Franke A; Lieb W; Thiele H; Altmüller J; Nürnberg P; Klaschik K; Ernst C; Ditsch N; Jessen F; Ramirez A; Wappenschmidt B; Engel C; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
    JAMA Oncol; 2017 Sep; 3(9):1245-1248. PubMed ID: 28033443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
    Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
    Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
    Kiiski JI; Fagerholm R; Tervasmäki A; Pelttari LM; Khan S; Jamshidi M; Mantere T; Pylkäs K; Bartek J; Bartkova J; Mannermaa A; Tengström M; Kosma VM; Winqvist R; Kallioniemi A; Aittomäki K; Blomqvist C; Nevanlinna H
    Int J Cancer; 2016 Dec; 139(12):2760-2770. PubMed ID: 27542569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of candidate genes in Israeli male breast cancer cases.
    Schayek H; Korach H; Laitman Y; Bernstein-Molho R; Friedman E
    Breast Cancer Res Treat; 2018 Jul; 170(2):399-404. PubMed ID: 29560538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
    Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
    Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
    de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
    Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.
    Silvestri V; Rizzolo P; Falchetti M; Zanna I; Masala G; Bianchi S; Palli D; Ottini L
    Breast Cancer Res Treat; 2011 Apr; 126(2):539-43. PubMed ID: 21165771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
    Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
    BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
    Kiiski JI; Pelttari LM; Khan S; Freysteinsdottir ES; Reynisdottir I; Hart SN; Shimelis H; Vilske S; Kallioniemi A; Schleutker J; Leminen A; Bützow R; Blomqvist C; Barkardottir RB; Couch FJ; Aittomäki K; Nevanlinna H
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15172-7. PubMed ID: 25288723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
    Rizzolo P; Zelli V; Silvestri V; Valentini V; Zanna I; Bianchi S; Masala G; Spinelli AM; Tibiletti MG; Russo A; Varesco L; Giannini G; Capalbo C; Calistri D; Cortesi L; Viel A; Bonanni B; Azzollini J; Manoukian S; Montagna M; Peterlongo P; Radice P; Palli D; Ottini L
    Int J Cancer; 2019 Jul; 145(2):390-400. PubMed ID: 30613976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.
    Peterlongo P; Catucci I; Colombo M; Caleca L; Mucaki E; Bogliolo M; Marin M; Damiola F; Bernard L; Pensotti V; Volorio S; Dall'Olio V; Meindl A; Bartram C; Sutter C; Surowy H; Sornin V; Dondon MG; Eon-Marchais S; Stoppa-Lyonnet D; Andrieu N; Sinilnikova OM; ; Mitchell G; James PA; Thompson E; ; ; Marchetti M; Verzeroli C; Tartari C; Capone GL; Putignano AL; Genuardi M; Medici V; Marchi I; Federico M; Tognazzo S; Matricardi L; Agata S; Dolcetti R; Della Puppa L; Cini G; Gismondi V; Viassolo V; Perfumo C; Mencarelli MA; Baldassarri M; Peissel B; Roversi G; Silvestri V; Rizzolo P; Spina F; Vivanet C; Tibiletti MG; Caligo MA; Gambino G; Tommasi S; Pilato B; Tondini C; Corna C; Bonanni B; Barile M; Osorio A; Benitez J; Balestrino L; Ottini L; Manoukian S; Pierotti MA; Renieri A; Varesco L; Couch FJ; Wang X; Devilee P; Hilbers FS; van Asperen CJ; Viel A; Montagna M; Cortesi L; Diez O; Balmaña J; Hauke J; Schmutzler RK; Papi L; Pujana MA; Lázaro C; Falanga A; Offit K; Vijai J; Campbell I; Burwinkel B; Kvist A; Ehrencrona H; Mazoyer S; Pizzamiglio S; Verderio P; Surralles J; Rogan PK; Radice P
    Hum Mol Genet; 2015 Sep; 24(18):5345-55. PubMed ID: 26130695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.
    Palli D; Falchetti M; Masala G; Lupi R; Sera F; Saieva C; D'Amico C; Ceroti M; Rizzolo P; Caligo MA; Zanna I; Ottini L
    BMC Cancer; 2007 Sep; 7():170. PubMed ID: 17767707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
    Ottini L; Rizzolo P; Zanna I; Falchetti M; Masala G; Ceccarelli K; Vezzosi V; Gulino A; Giannini G; Bianchi S; Sera F; Palli D
    Breast Cancer Res Treat; 2009 Aug; 116(3):577-86. PubMed ID: 18819001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population.
    Morales-Pison S; Morales-González S; Fernandez-Ramires R; Tapia JC; Maldonado E; Calaf GM; Jara L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.
    Hallamies S; Pelttari LM; Poikonen-Saksela P; Jekunen A; Jukkola-Vuorinen A; Auvinen P; Blomqvist C; Aittomäki K; Mattson J; Nevanlinna H
    BMC Cancer; 2017 Sep; 17(1):620. PubMed ID: 28874143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
    Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
    BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.